gamma-aminobutyric acid has been researched along with Cerebrovascular Disorders in 36 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The therapeutic efficacy of GABA was compared with pyrithioxine and placebo in 432 patients with cerebrovascular disorders by a multi-center (50 hospitals) double-blind clinical trial." | 9.05 | Clinical evaluation of GABA in the treatment of cerebrovascular disorders. Multi-center double-blind study in comparison with pyrithioxine and placebo. ( Araki, G; Kurihara, M; Mori, A; Otomo, E, 1981) |
| "GABA and Piracetam caused the improvement of the morphological state of cerebral infarction, due to intracarotid infusion of Arachidonic acid." | 7.68 | [Effects of GABA and piracetam on the development of experimental cerebral infarction in rats and platelet aggregation in patients with cerebrovascular disorders]. ( Amroian, EA; Balian, LS; Parsamian, LK; Vartazarian, ND, 1990) |
| "The therapeutic efficacy of GABA was compared with pyrithioxine and placebo in 432 patients with cerebrovascular disorders by a multi-center (50 hospitals) double-blind clinical trial." | 5.05 | Clinical evaluation of GABA in the treatment of cerebrovascular disorders. Multi-center double-blind study in comparison with pyrithioxine and placebo. ( Araki, G; Kurihara, M; Mori, A; Otomo, E, 1981) |
| "GABA and Piracetam caused the improvement of the morphological state of cerebral infarction, due to intracarotid infusion of Arachidonic acid." | 3.68 | [Effects of GABA and piracetam on the development of experimental cerebral infarction in rats and platelet aggregation in patients with cerebrovascular disorders]. ( Amroian, EA; Balian, LS; Parsamian, LK; Vartazarian, ND, 1990) |
| " Individualization of dosage and avoidance of unnecessary polypharmacy are essential for safe utilization of anti-epileptic drugs." | 2.44 | [Epilepsy in the elderly]. ( Yoshino, A, 2007) |
| "Although epilepsy was believed to have the highest incidence in childhood, recent epidemiologic studies revealed that the incidence increases markedly in elderly." | 2.44 | [Epilepsy in the elderly]. ( Yoshino, A, 2007) |
| " The dose-response curve of ifenprodil tartrate was shifted to the left by pre-incubation in calcium hopantenate." | 1.27 | A possible mechanism on the potentiating vascular effect of coadministration of ifenprodil tartrate and calcium hopantenate: a study in the internal carotid artery. ( Honda, H; Irino, O; Iwata, T; Izumisawa, M; Matsuda, H; Shibuya, T; Shimura, H; Tsuji, H; Watanabe, Y, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (80.56) | 18.7374 |
| 1990's | 4 (11.11) | 18.2507 |
| 2000's | 2 (5.56) | 29.6817 |
| 2010's | 1 (2.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Volotova, EV | 1 |
| Kurkin, DV | 1 |
| Mazina, NV | 1 |
| Berestovitskaia, VM | 1 |
| Vasil'eva, OS | 1 |
| Mikhaĭlova, NA | 1 |
| Kamchatov, PR | 1 |
| HIRAKI, K | 1 |
| IRINO, S | 1 |
| ASANO, T | 1 |
| YAMAMOTO, S | 1 |
| HARAOKA, T | 1 |
| HASHIMOTO, Y | 1 |
| MURAKAMI, B | 1 |
| Yoshino, A | 1 |
| Weinberger, J | 1 |
| Cohen, G | 1 |
| Hall, ED | 1 |
| Becker, RE | 1 |
| Lal, H | 1 |
| Jellinger, K | 1 |
| Riederer, P | 1 |
| Ohtomo, E | 1 |
| Otomo, E | 1 |
| Araki, G | 1 |
| Mori, A | 1 |
| Kurihara, M | 1 |
| Eninia, GI | 1 |
| Smeltere, ES | 1 |
| Godlevska, MA | 1 |
| Uzulinia, IP | 1 |
| Stahl, JS | 1 |
| Rottach, KG | 1 |
| Averbuch-Heller, L | 1 |
| von Maydell, RD | 1 |
| Collins, SD | 1 |
| Leigh, RJ | 1 |
| Ishihara, N | 1 |
| Gotoh, F | 1 |
| Achar, VS | 2 |
| Welch, KM | 2 |
| Chabi, E | 2 |
| Bartosh, K | 1 |
| Meyer, JS | 1 |
| Nell, JH | 1 |
| Nartosh, K | 1 |
| Chee, AN | 1 |
| Mathew, NT | 1 |
| Symon, L | 1 |
| Branston, NM | 1 |
| Strong, AJ | 1 |
| Hope, TD | 1 |
| Mirzoian, SA | 1 |
| Akopian, VP | 1 |
| Mankovskiĭ, NB | 1 |
| Kostiuchenko, VG | 1 |
| Penek, NV | 1 |
| Lukashevich, LP | 1 |
| Samosiuk, IZ | 1 |
| Filonchik, AA | 1 |
| Amroian, EA | 1 |
| Vartazarian, ND | 1 |
| Parsamian, LK | 1 |
| Balian, LS | 1 |
| Schallert, T | 1 |
| Jones, TA | 1 |
| Lindner, MD | 1 |
| Yano, S | 1 |
| Mizuno, M | 1 |
| Watanabe, K | 1 |
| Bruhn, H | 1 |
| Frahm, J | 1 |
| Gyngell, ML | 1 |
| Merboldt, KD | 1 |
| Hänicke, W | 1 |
| Sauter, R | 1 |
| Hashimoto, T | 1 |
| Kimori, M | 1 |
| Nakamura, Y | 1 |
| Kuriyama, K | 1 |
| Hirai, S | 1 |
| Palmer, GC | 1 |
| Jones, EG | 1 |
| Bando, K | 1 |
| Hatanaka, Y | 1 |
| Ohbayashi, S | 1 |
| Irino, O | 2 |
| Shibuya, T | 1 |
| Honda, H | 1 |
| Watanabe, Y | 1 |
| Shimura, H | 1 |
| Matsuda, H | 1 |
| Tsuji, H | 1 |
| Izumisawa, M | 1 |
| Iwata, T | 1 |
| Zinchenko, VA | 2 |
| Popov, EA | 1 |
| Kalinichev, SN | 1 |
| Lobzhanidze, PV | 1 |
| Gottlieb, D | 1 |
| Shahin, D | 1 |
| Palaguta, VD | 1 |
| Sytinskiĭ, IA | 1 |
| Melanich, NN | 1 |
| Tsyrul'nikova, LG | 1 |
| Pigarev, VA | 1 |
| Borromei, A | 1 |
9 reviews available for gamma-aminobutyric acid and Cerebrovascular Disorders
| Article | Year |
|---|---|
[Epilepsy in the elderly].
Topics: Aged; Aged, 80 and over; Aging; Amines; Anticonvulsants; Cerebrovascular Disorders; Comorbidity; Cyc | 2007 |
Glucocorticoid effects on central nervous excitability and synaptic transmission.
Topics: Acetylcholine; Animals; Biomechanical Phenomena; Brain; Cats; Cell Membrane; Central Nervous System; | 1982 |
Pharmacological approaches to treatment of hemiballism and hemichorea.
Topics: Acetylcholine; Antipsychotic Agents; Basal Ganglia; Cerebrovascular Disorders; Chorea; Diazepam; Dop | 1983 |
[Recent advances in brain metabolic activators].
Topics: Aged; Amantadine; Animals; Brain; Cats; Cerebrovascular Circulation; Cerebrovascular Disorders; Clin | 1984 |
[Cerebral metabolic activator (author's transl)].
Topics: Adenosine Triphosphate; Animals; Barbiturates; Biogenic Amines; Biotransformation; Brain; Brain Isch | 1979 |
Multilevel transneuronal degeneration after brain damage. Behavioral events and effects of anticonvulsant gamma-aminobutyric acid-related drugs.
Topics: Animals; Atrophy; Behavior, Animal; Cerebrovascular Disorders; Corpus Striatum; Diazepam; gamma-Amin | 1990 |
Cyclic nucleotides in stroke and related cerebrovascular disorders.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Adenosine; Adenylyl Cyclas | 1985 |
Neurotransmitters in the cerebral cortex.
Topics: Acetylcholine; Alzheimer Disease; Animals; Cerebral Cortex; Cerebrovascular Disorders; Dementia; Dop | 1986 |
[Some therapeutic effects of GABA in neurology (author's transl)].
Topics: Aminobutyrates; Brain; Brain Diseases; Brain Injuries; Cerebrovascular Disorders; Coma; Epilepsy; ga | 1974 |
2 trials available for gamma-aminobutyric acid and Cerebrovascular Disorders
| Article | Year |
|---|---|
[Recent advances in brain metabolic activators].
Topics: Aged; Amantadine; Animals; Brain; Cats; Cerebrovascular Circulation; Cerebrovascular Disorders; Clin | 1984 |
Clinical evaluation of GABA in the treatment of cerebrovascular disorders. Multi-center double-blind study in comparison with pyrithioxine and placebo.
Topics: Aged; Cerebrovascular Disorders; Clinical Trials as Topic; Double-Blind Method; Electroencephalograp | 1981 |
26 other studies available for gamma-aminobutyric acid and Cerebrovascular Disorders
| Article | Year |
|---|---|
[Comparative analysis of action of beta-phenyl derivatives of glutamic and gamma-aminobutyric acid on cerebral blood flow and cerebrovascular endothelium after irreversible occlusion of the common carotid artery].
Topics: Animals; Blood Flow Velocity; Brain; Carotid Artery, Common; Cerebrovascular Disorders; Endothelium, | 2013 |
[The use of pantogam in patients with moderate cognitive disorders of vascular genesis].
Topics: Aged; Cerebrovascular Disorders; Cognition Disorders; Female; gamma-Aminobutyric Acid; Humans; Male; | 2009 |
[Experience in the use of gamma-aminobutyric acid in our clinic].
Topics: Ambulatory Care Facilities; Amino Acids; Antifibrinolytic Agents; Cerebrovascular Disorders; gamma-A | 1962 |
[On the therapeutic effectiveness of gamma-aminobutyric acid and gamma-amino-beta-hydroxybutyric acid for cerebrovascular disorders and hypertension].
Topics: Amino Acids; Antifibrinolytic Agents; Cerebrovascular Disorders; gamma-Aminobutyric Acid; Hypertensi | 1962 |
[Some experiences with the use of gamma-aminobutyric acid (GABA), especially in cases of coma and disorders caused by disturbances of cerebral circulation].
Topics: Amino Acids; Cerebrovascular Circulation; Cerebrovascular Disorders; Coma; Electroconvulsive Therapy | 1961 |
The differential effect of ischemia on the active uptake of dopamine, gamma-aminobutyric acid, and glutamate by brain synaptosomes.
Topics: Animals; Brain; Brain Ischemia; Carotid Arteries; Cerebrovascular Disorders; Dopamine; gamma-Aminobu | 1982 |
[Central neurotransmitters in cerebral ischemia and stroke].
Topics: Animals; Blood-Brain Barrier; Brain Edema; Brain Ischemia; Cerebral Infarction; Cerebrovascular Diso | 1983 |
[Effect of gamma-aminobutyric acid preparations on cerebral circulation in chronic cerebrovascular insufficiency].
Topics: Blood Pressure; Brachial Artery; Cerebrovascular Circulation; Cerebrovascular Disorders; Chronic Dis | 1982 |
A pilot study of gabapentin as treatment for acquired nystagmus.
Topics: Acetates; Adult; Amines; Anticonvulsants; Brain Stem; Cerebrovascular Disorders; Cyclohexanecarboxyl | 1996 |
Cerebrospinal fluid gamma-aminobutyric acid in neurologic disease.
Topics: Aminobutyrates; Cerebrovascular Disorders; Dementia; Epilepsy, Post-Traumatic; Epilepsy, Temporal Lo | 1976 |
Biochemical comparison of migraine and stroke.
Topics: Aminobutyrates; Cerebrovascular Disorders; Cyclic AMP; gamma-Aminobutyric Acid; Humans; Migraine Dis | 1976 |
The concepts of thresholds of ischaemia in relation to brain structure and function.
Topics: Animals; Cell Membrane; Cerebral Cortex; Cerebrovascular Disorders; Disease Models, Animal; Evoked P | 1977 |
[GABA system as a factor facilitating the development of compensation of disordered cerebral hemodynamics].
Topics: Adaptation, Physiological; Aminobutyrates; Animals; Brain; Cats; Cerebrovascular Disorders; Dogs; ga | 1978 |
[Effectiveness of gammalon and anticholinesterase preparations in the restorative and residual periods of ischemic stroke in old age].
Topics: Age Factors; Aged; Aminobutyrates; Cerebrovascular Disorders; Drug Evaluation; Female; Galantamine; | 1976 |
[Use of certain preparations of gamma-aminobutyric acid in diseases of the nervous system].
Topics: Adolescent; Adult; Aged; Aminobutyrates; Brain Injuries; Cerebrovascular Disorders; Child; Drug Eval | 1975 |
[Effects of GABA and piracetam on the development of experimental cerebral infarction in rats and platelet aggregation in patients with cerebrovascular disorders].
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Brain; Cerebral Infarction; Cerebrovascular Disorders; | 1990 |
Stimulatory effect of some therapeutic drugs used for improving cerebral insufficiency on gastric acid secretion in rats.
Topics: Animals; Atropine; Baclofen; Carbachol; Cerebrovascular Disorders; Cytidine Diphosphate Choline; gam | 1990 |
Cerebral metabolism in man after acute stroke: new observations using localized proton NMR spectroscopy.
Topics: Adult; Aspartic Acid; Brain; Brain Ischemia; Cerebral Infarction; Cerebrovascular Disorders; gamma-A | 1989 |
Effect of NC-1100 [1-(3,4-dimethoxyphenyl)-2-(4-diphenylmethylpiperazinyl) ethanol dihydrochloride] on gamma-aminobutyric acid (GABA) metabolism in rat brain: analysis using stroke-prone spontaneously hypertensive rat.
Topics: 4-Aminobutyrate Transaminase; Amino Acids; Animals; Brain; Cerebrovascular Disorders; gamma-Aminobut | 1989 |
[Agents to improve cerebrovascular circulation and cerebral metabolism--general concepts and classification of the drugs].
Topics: Adenosine Triphosphate; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Brain; Cerebrovascul | 1985 |
[A quantitative measurement of the cerebral infarct focus induced by arachidonate infusion and the relationship between measured values and stroke signs].
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Brain; Cerebral Infarction; Cerebrovascular Disorders; | 1988 |
A possible mechanism on the potentiating vascular effect of coadministration of ifenprodil tartrate and calcium hopantenate: a study in the internal carotid artery.
Topics: Animals; Blood Flow Velocity; Calcium; Carotid Artery, Internal; Cerebrovascular Disorders; Dogs; Dr | 1988 |
[Use of pikamilon in the combined treatment of patients with cerebral circulatory disorders].
Topics: Adult; Aged; Brain; Cerebrovascular Disorders; Combined Modality Therapy; Drug Combinations; Drug Ev | 1988 |
[Hemiballism and its treatment].
Topics: Cerebrovascular Disorders; Dopamine Antagonists; gamma-Aminobutyric Acid; Humans; Movement Disorders | 1987 |
[Nootropic drugs in the acute period of cerebral stroke].
Topics: Acute Disease; Cerebrovascular Disorders; Drug Therapy, Combination; gamma-Aminobutyric Acid; Humans | 1985 |
[Blood serotonin during gammalon treatment of patients with acute cerebrovascular disorders].
Topics: Acute Disease; Adult; Aged; Aminobutyrates; Cerebrovascular Disorders; Female; gamma-Aminobutyric Ac | 1974 |